Roche's key drugs lift sales by 7% at CER despite FX headwinds. The company expects mid-single digit sales growth in 2026.
Earnings Call Insights: Qiagen N.V. (NYSE:QGEN) Q4 2024 Thierry Bernard, CEO, highlighted that Qiagen surpassed its Q4 2024 ...
SOUTH SAN FRANCISCO, Calif., Nov. 11, 2024 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of ...
CALGARY, AB, June 15, 2023 /CNW/ - The Canada Energy Regulator (CER) has improved the methodology for how companies fund future pipeline abandonment. This will enhance our ability to ensure that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results